NRXS
NeurAxis, Inc.
1W: +11.1%
1M: +42.4%
3M: +176.1%
YTD: +70.8%
1Y: +232.8%
$7.62
+0.46 (+6.42%)
After Hours: $7.83 (+0.21, +2.82%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$81.2M
52W Range1.33-7.943
Volume605,603
Avg Volume160,455
Beta2.49
Dividend—
Analyst Ratings
Company Info
CEOBrian Carrico
Employees21
SectorHealthcare
IndustryBiotechnology
IPO Date2023-08-09
Websiteneuraxis.com
11550 North Meridian Street
Carmel, IN 46032
US
Carmel, IN 46032
US
(812) 689-0791
About NeurAxis, Inc.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Miranda Adrian | A-Award | 47,569 | — | 2026-01-22 |
| Watkins Bradley Mitc | A-Award | 21,598 | $4.63 | 2026-01-22 |
| Keyser Jane Elizabet | A-Award | 21,598 | $4.63 | 2026-01-22 |
| Henrichs Timothy Rob | A-Award | 75,231 | — | 2026-01-22 |
| Carrico Thomas Joese | A-Award | 47,569 | — | 2026-01-22 |